The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Breath Condensate Study in Patients With Cystic Fibrosis.

NCT02056132 ·Status: COMPLETED

Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort

NCT01862211 ·Status: COMPLETED ·Phase: NA

Idiopathic Pulmonary Fibrosis: a Case-control Study

NCT00005295 ·Status: TERMINATED

Connexin Genotypes in Cystic Fibrosis

NCT04242420 ·Status: UNKNOWN ·Phase: NA

Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis

NCT00850551 ·Status: COMPLETED ·Phase: NA

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

NCT01676688 ·Status: COMPLETED

Evaluation of Salt Status in Patients With Cystic Fibrosis

NCT04556162 ·Status: COMPLETED

Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis

NCT00004533 ·Status: COMPLETED ·Phase: PHASE1

Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

NCT00585364 ·Status: COMPLETED

G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)

NCT01521338 ·Status: COMPLETED

Diagnosis and Treatment of Patients With Cystic Fibrosis

NCT00001223 ·Status: TERMINATED

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

NCT06747858 ·Status: RECRUITING ·Phase: PHASE2

The Role of Bacteria and Genetic Variations in Cystic Fibrosis

NCT00043225 ·Status: COMPLETED

Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group

NCT00221559 ·Status: COMPLETED

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

NCT00499837 ·Status: COMPLETED ·Phase: PHASE2

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

NCT02109822 ·Status: COMPLETED

Clinical Performance of the AtbFinder® Test System for Selection of Antibiotic Therapy in Persons With Cystic Fibrosis

NCT05584982 ·Status: COMPLETED ·Phase: NA

Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations

NCT03256799 ·Status: COMPLETED ·Phase: PHASE4

FDG-PET Imaging in Young Cystic Fibrosis Patients

NCT00846053 ·Status: COMPLETED ·Phase: NA

Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies

NCT05100823 ·Status: TERMINATED ·Phase: NA

Analysis of Specimens From Individuals With Pulmonary Fibrosis

NCT00084305 ·Status: ACTIVE_NOT_RECRUITING

A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)

NCT02477319 ·Status: COMPLETED

Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test

NCT03584841 ·Status: UNKNOWN ·Phase: NA

Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis

NCT05604495 ·Status: RECRUITING

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

NCT05639556 ·Status: ACTIVE_NOT_RECRUITING